179 related articles for article (PubMed ID: 33635863)
1. Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.
Bouman JA; Riou J; Bonhoeffer S; Regoes RR
PLoS Comput Biol; 2021 Feb; 17(2):e1008728. PubMed ID: 33635863
[TBL] [Abstract][Full Text] [Related]
2. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
[TBL] [Abstract][Full Text] [Related]
3. Evaluating a SARS-CoV-2 screening strategy based on serological tests.
Baccini M; Mattei A; Rocco E; Vannucci G; Mealli F
Epidemiol Prev; 2020; 44(5-6 Suppl 2):193-199. PubMed ID: 33412810
[TBL] [Abstract][Full Text] [Related]
4. Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts.
Bortz RH; Florez C; Laudermilch E; Wirchnianski AS; Lasso G; Malonis RJ; Georgiev GI; Vergnolle O; Herrera NG; Morano NC; Campbell ST; Orner EP; Mengotto A; Dieterle ME; Fels JM; Haslwanter D; Jangra RK; Celikgil A; Kimmel D; Lee JH; Mariano MC; Nakouzi A; Quiroz J; Rivera J; Szymczak WA; Tong K; Barnhill J; Forsell MNE; Ahlm C; Stein DT; Pirofski LA; Goldstein DY; Garforth SJ; Almo SC; Daily JP; Prystowsky MB; Faix JD; Fox AS; Weiss LM; Lai JR; Chandran K
mSphere; 2021 Apr; 6(2):. PubMed ID: 33883259
[TBL] [Abstract][Full Text] [Related]
5. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
[TBL] [Abstract][Full Text] [Related]
6. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
7. The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital.
Lapić I; Rogić D; Šegulja D; Kralik Oguić S; Knežević J
Croat Med J; 2020 Dec; 61(6):485-490. PubMed ID: 33410294
[TBL] [Abstract][Full Text] [Related]
8. The risk of over-diagnosis in serological testing. Implications for communications strategies.
Biggeri A; Forni S; Braga M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):184-192. PubMed ID: 33412809
[TBL] [Abstract][Full Text] [Related]
9. Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva.
Bouman JA; Kadelka S; Stringhini S; Pennacchio F; Meyer B; Yerly S; Kaiser L; Guessous I; Azman AS; Bonhoeffer S; Regoes RR
Epidemics; 2022 Jun; 39():100572. PubMed ID: 35580458
[TBL] [Abstract][Full Text] [Related]
10. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
[TBL] [Abstract][Full Text] [Related]
11. Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model.
Glemain B; de Lamballerie X; Zins M; Severi G; Touvier M; Deleuze JF; ; Lapidus N; Carrat F
Sci Rep; 2024 Apr; 14(1):9503. PubMed ID: 38664455
[TBL] [Abstract][Full Text] [Related]
12. Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.
Jiang JC; Zhang Y
Biochem Soc Trans; 2020 Dec; 48(6):2851-2863. PubMed ID: 33170924
[TBL] [Abstract][Full Text] [Related]
13. Performance characteristics of five SARS-CoV-2 serological assays: Clinical utility in health-care workers.
Heffernan E; Kennedy L; Hannan MM; Ramlaul N; Denieffe S; Courtney G; Watt A; Hurley J; Lynch M; Fitzgibbon M
Ann Clin Biochem; 2021 Sep; 58(5):496-504. PubMed ID: 33845592
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.
Rathe JA; Hemann EA; Eggenberger J; Li Z; Knoll ML; Stokes C; Hsiang TY; Netland J; Takehara KK; Pepper M; Gale M
J Infect Dis; 2021 Apr; 223(7):1120-1131. PubMed ID: 33367830
[TBL] [Abstract][Full Text] [Related]
15. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
16. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
[TBL] [Abstract][Full Text] [Related]
17. Correcting for Antibody Waning in Cumulative Incidence Estimation From Sequential Serosurveys.
Kadelka S; Bouman JA; Ashcroft P; Regoes RR
Am J Epidemiol; 2024 May; 193(5):777-786. PubMed ID: 38012125
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies.
James J; Rhodes S; Ross CS; Skinner P; Smith SP; Shipley R; Warren CJ; Goharriz H; McElhinney LM; Temperton N; Wright E; Fooks AR; Clark TW; Brookes SM; Brown IH; Banyard AC
Viruses; 2021 Apr; 13(4):. PubMed ID: 33924168
[TBL] [Abstract][Full Text] [Related]
19. Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels.
Bottomley C; Otiende M; Uyoga S; Gallagher K; Kagucia EW; Etyang AO; Mugo D; Gitonga J; Karanja H; Nyagwange J; Adetifa IMO; Agweyu A; Nokes DJ; Warimwe GM; Scott JAG
Nat Commun; 2021 Oct; 12(1):6196. PubMed ID: 34702829
[TBL] [Abstract][Full Text] [Related]
20. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
